CD90+ fibroblasts are involved in various pathological processes, such as the induction of pulmonary fibrosis, regulation of inflammatory arthritis, involvement in inflammatory skin diseases, and skin scar formation, and can be used as biomarkers for related cancers (Table 2). Here, THY1 is linked to pulmonary fibrosis.